Published in J Dent Res on June 01, 1997
Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev (1998) 6.28
The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol (2005) 1.71
Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000 (2010) 1.65
Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect Immun (1999) 1.61
In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun (2004) 1.26
Gene expression in Porphyromonas gingivalis after contact with human epithelial cells. Infect Immun (2005) 1.22
Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun (2005) 1.21
Bacterial invasion of epithelial cells and spreading in periodontal tissue. Periodontol 2000 (2010) 1.15
Targeted disruption of fibronectin-integrin interactions in human gingival fibroblasts by the RI protease of Porphyromonas gingivalis W50. Infect Immun (1999) 1.10
Porphyrin-mediated binding to hemoglobin by the HA2 domain of cysteine proteinases (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis. J Bacteriol (1999) 1.08
Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis. Infect Immun (1999) 1.08
Discrete proteolysis of focal contact and adherens junction components in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for cell adhesion and migration disabling. Infect Immun (2002) 1.06
Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther (2006) 0.95
Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol (2002) 0.94
Assessment of IL-6, IL-8 and TNF-α levels in the gingival tissue of patients with periodontitis. Exp Ther Med (2013) 0.93
Inhibition of trypsin-like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother (2001) 0.92
Hydrolysis of interleukin-12 by Porphyromonas gingivalis major cysteine proteinases may affect local gamma interferon accumulation and the Th1 or Th2 T-cell phenotype in periodontitis. Infect Immun (2001) 0.91
Porphyrin-mediated cell surface heme capture from hemoglobin by Porphyromonas gingivalis. J Bacteriol (2003) 0.91
Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains. PLoS One (2013) 0.90
Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis. Infect Immun (2005) 0.90
Activation of neutrophil collagenase in periodontitis. Infect Immun (1999) 0.86
Cleavage of human transferrin by Porphyromonas gingivalis gingipains promotes growth and formation of hydroxyl radicals. Infect Immun (2004) 0.86
Enhancement of Th2 pathways and direct activation of B cells by the gingipains of Porphyromonas gingivalis. Clin Exp Immunol (2003) 0.83
Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases. Infect Immun (2002) 0.83
Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. Biochem J (2009) 0.83
[Pathogenesis of parodontitis in rheumatic diseases]. Z Rheumatol (2010) 0.81
Porphyromonas gingivalis promotes monocyte migration by activating MMP-9. J Periodontal Res (2011) 0.79
Proteolytic Activities of Oral Bacteria on ProMMP-9 and the Effect of Synthetic Proteinase Inhibitors. Open Dent J (2008) 0.79
Correlation of expression and activity of matrix metalloproteinase-9 and -2 in human gingival cells of periodontitis patients. J Periodontal Implant Sci (2013) 0.78
Humoral responses to Porphyromonas gingivalis gingipain adhesin domains in subjects with chronic periodontitis. Infect Immun (2004) 0.78
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A (1990) 4.46
Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A (1990) 2.68
Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun (1982) 1.91
Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem (1991) 1.59
Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res (1988) 1.56
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Catabolism and turnover of collagens: collagenases. Methods Enzymol (1987) 1.44
Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res (2000) 1.43
Sequence specificities of human fibroblast and neutrophil collagenases. J Biol Chem (1991) 1.34
Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem (2000) 1.31
Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme. Biochemistry (1988) 1.30
Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem (1992) 1.28
Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal Biochem (1991) 1.28
Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem (1987) 1.20
Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem (1993) 1.16
TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci (2001) 1.16
Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. J Biol Chem (1989) 1.10
Synthesis and release of procollagenase by cultured fibroblasts. J Biol Chem (1976) 1.09
Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol (2001) 1.07
A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol (2001) 1.07
Kinetics of acid demineralization in histologic technique. J Histochem Cytochem (1974) 1.05
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry (1993) 1.04
Procollagenase from bovine gingiva. Biochim Biophys Acta (1976) 1.03
Proteins of the periodontium. Identification of collagens with the [alpha1(I)]2alpha2 and [alpha1(III)]3 structures in bovine periodontal ligament. J Biol Chem (1975) 1.01
Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta (2000) 1.00
Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood (2001) 0.99
Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry (1990) 0.98
Activation of fibroblast procollagenase by mast cell proteases. Biochim Biophys Acta (1976) 0.95
Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry (1991) 0.95
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol (2001) 0.95
Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. J Biol Chem (2001) 0.94
Trypsin activation of latent collagenase from several mammalian sources. Scand J Dent Res (1975) 0.93
Production of three plasminogen activators and an inhibitor in keratinocyte cultures. Biochim Biophys Acta (1983) 0.93
Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J Immunol (1998) 0.93
Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J Biol Chem (1994) 0.92
Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res (2001) 0.92
Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta (1995) 0.91
Degradation of type I collagen by rat mucosal keratinocytes. Evidence for secretion of a specific epithelial collagenase. J Biol Chem (1987) 0.90
An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry (1991) 0.90
Induction of matrix metalloproteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase. J Periodontal Res (1998) 0.90
Proteolytic activity in developing bovine enamel. J Dent Res (1979) 0.90
Remaining dentine thickness and human pulp responses. Int Endod J (2003) 0.88
Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis. Immunol Invest (1989) 0.87
Nicotine increases the collagen-degrading ability of human gingival fibroblasts. J Periodontal Res (2007) 0.87
Purification of an 80,000-Mr glycylprolyl peptidase from Bacteroides gingivalis. Infect Immun (1989) 0.87
Dissolution of type I collagen fibrils by gingival fibroblasts isolated from patients of various periodontitis categories. J Periodontal Res (1998) 0.87
Activation of latent bovine gingival collagenase. Arch Oral Biol (1975) 0.86
Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol (1993) 0.86
Proteolytic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at a single active site. Biochemistry (1990) 0.86
Hemagglutinin activity and heterogeneity of related Porphyromonas gingivalis proteinases. Oral Microbiol Immunol (1997) 0.86
Collagenolytic activity in crevicular fluid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J Periodontal Res (1987) 0.86
Cloning, characterization, and expression analysis of mouse enamelysin. J Dent Res (2000) 0.86
Evidence for an extracellular plasmin-dependent proteolytic system in mineralizing matrices. Calcif Tissue Int (1984) 0.86
Functional domains of human TIMP-1 (tissue inhibitor of metalloproteinases). J Biol Chem (1994) 0.86
APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochemistry (1996) 0.86
Activation of keratinocyte-mediated collagen (type I) breakdown by suspected human periodontopathogen. Evidence of a novel mechanism of connective tissue breakdown. J Periodontal Res (1984) 0.86
Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J Protein Chem (1996) 0.85
Replacement of conserved cysteines in human tissue inhibitor of metalloproteinases-1. J Biol Chem (1997) 0.85
Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1. Protein Eng (2000) 0.84
Cleavage of bovine skin type III collagen by proteolytic enzymes. Relative resistance of the fibrillar form. J Biol Chem (1985) 0.84
Heterogeneity in the collagen-degrading ability of Porphyromonas gingivalis-stimulated human gingival fibroblasts. J Periodontal Res (2007) 0.83
Murine TIMP-2 gene-targeted mutation. Ann N Y Acad Sci (1999) 0.82
Proteins of the periodontium. Characterization of the insoluble collagens of bovine dental cementum. Calcif Tissue Res (1977) 0.82
Localization of cleavage sites for human fibroblast collagenase in the bait region of five mammalian alpha-macroglobulins. Matrix Suppl (1992) 0.81
Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. J Cell Physiol (1997) 0.80
Using HSV-thymidine kinase for safety in an allogeneic salivary graft cell line. Tissue Eng (2001) 0.80
Comparison of pulp responses to resin composites. Oper Dent (2003) 0.80
In vivo and in vitro stimulation of collagenase production by rabbit alveolar macrophages. Arch Oral Biol (1976) 0.80
Analysis of the TIMP-1/FIB-CL complex. Ann N Y Acad Sci (1994) 0.79
Inhibition of molar eruption and root elongation in MT1-MMP-deficient mice. Connect Tissue Res (2003) 0.79
92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. J Dent Res (1999) 0.79
Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1). Biochim Biophys Acta (1998) 0.79
Expression of collagenase and IL-1 alpha in developing rat hearts. Dev Dyn (1992) 0.79